Companion Diagnostics Market Report

Home Healthcare And Pharmaceutical Companion Diagnostics Market Report

Companion Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product & Service (Assays, Kits & Reagents, Software & Services); By Technology (Polymerase Chain Reaction, Next-generation Sequencing, In-Situ Hybridization, Immunohistochemistry); By Indication (Cancer, Neurological Disorders, Cardiovascular Diseases, Infectious Diseases); By End User (Pharmaceutical & Biopharmaceutical, Reference Laboratories, Contract Research Organizations); By Region (North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA))

Published Date: February 2023
Report ID: BWC20380
Available Format: PDF
Page: 400

Report Overview

Increasing cases of adverse drug reactions and co-development of drug and diagnostic technology are projected to propel the expansion of global companion diagnostics market during the forecast period between 2023 and 2029.

Global Companion Diagnostics Market - Industry Trends & Forecast Report, 2029

Global companion diagnostics market size was estimated at USD 6.12 billion in 2022. During the forecast period between 2023 and 2029, the size of global companion diagnostics market is projected to grow at CAGR of 12.15% reaching a value of USD 13.57 billion by 2029. Major growth drivers for global companion diagnostics market include increasing requirement for personalized treatment, broad application areas of companion diagnostics, surging demand for focused therapy, growing cancer occurrences, and development of new biomarkers for various illnesses. Personalized medicine is becoming increasingly popular as the field of genetics and genetic engineering expands fast. It is now possible to provide the correct medicine to the right individual at the right time based on a person's genetic features. As part of a patient-centric drug development approach, many pharmaceutical and biopharmaceutical companies are developing targeted medication therapies. Numerous third-party companion diagnostic services provide similar services to enterprises that face a greater financial strain. As a result, the issue of high startup expenses has been effectively handled. These reasons are projected to drive the companion diagnostics market during the forecast period.

Global Companion Diagnostics Market

Global Companion Diagnostics Market – Overview

A companion diagnostics device is a medical gadget that is used in conjunction with therapeutic medications to assess the effect and applicability of drugs on a specific human body. Companion diagnostics are developed in tandem with medications to select or exclude patient groups based on the features to which they respond to therapy. This device assists the healthcare provider in determining whether a specific treatment is beneficial to the patient. In 2020, Roche gained FDA approval for Cobas EGFR Mutation Test v2 companion diagnostic for EGFR tyrosine kinase inhibitor for lung cancer treatment. Companion Diagnostic (CDx) is a clinical test created in collaboration with a therapeutic medicine to identify responders and non-responders to that therapy. It is done to determine which patient groups may and cannot be treated with the relevant medicine. CDx assists practitioners in determining the benefits, side effects, and hazards connected with therapeutic drug intake, guaranteeing patient safety. Growing patient preferences for customized therapy, expanding applications of personalized medications, increased prevalence of chronic diseases, and rising occurrences of allergies in patients as a result of medication adverse effects all contribute to the development of customized CDx, propelling the global Companion Diagnostics Market forward. Furthermore, CDx tests' features, such as cost-effectiveness, high sensitivity, and rapid and precise results in short timeframes, aid in the expansion of the companion diagnostics market.

Global Companion Diagnostics Market

Growth Drivers

Rapid Adoption of Technology Advancements

The companion indicative tests based on next-generation sequencing intend to open nuclear information from each persistent development genome to coordinate treatment decisions for disease medicines. When compared to previous sequencing technologies, forward sequencing detects more biomarkers for diverse drugs in a shorter period of time. The use of NGS sheets for biomarker assessment in a single test may aid in the treatment of a wide range of disorders. The many inventive degrees of improvement in NGS also give market participants a quick advantage over players providing other advancements such as PCR, ICH, and ISH. As a result, key market participants are concentrating on creating amigo illustrative goods in light of NGS.

Restraints

Expensive & Underutilized Companion Diagnostic Approaches

While immunotherapy has demonstrated a vital guarantee in cancer treatment, its high cost has limited widespread availability. Doctors may prefer to combine therapies, which could increase the length of the treatment from five months to more than three years. In this case, the longer the time, the more noticeable the cost. Also, the cost of personalized immunotherapies is significant. Disease immunotherapies can be significantly more expensive than other treatment options, like as chemotherapy or radiation therapy. As a result, the high cost of immuno-oncology treatments is expected to stymie the growth of the companion diagnostics industry.

Impact of COVID-19 on Global Companion Diagnostics Market

COVID-19 had a detrimental impact on the companion diagnostics market. In addition, prominent market participants witnessed a considerable drop in income owing to a fall in testing volume and other variables. In terms of sales, the market grew by 15.1% in 2020, compared to 19.8% in 2019. Revenue generated by the major players decreased significantly in 2020. However, the lifting of lockdown restrictions, stay-at-home orders in many nations, the introduction of novel diagnostic tests, and the re-establishment of the supply chain network were major contributors in the recovery of testing in 2021. As a result, the restart of cancer diagnostics testing and the introduction of novel diagnostic tests boosted demand in 2021.

Global Companion Diagnostics Market

Segmental Coverage

Global Companion Diagnostics Market – By Product & Service

By product & service, global companion diagnostics market is bifurcated into Assays, Kits & Reagents and Software & Services segments. The assays, kits, and reagents segment held the highest market share in 2020, owing to the availability of a diverse product portfolio and the rising use of assays and kits in many therapeutic areas.

Companion Diagnostics Market Size

Global Companion Diagnostics Market – By Technology

Based on technology, global companion diagnostics market is divided into Polymerase Chain Reaction, Next-generation Sequencing, In Situ Hybridization, and Immunohistochemistry. The Polymerase Chain Reaction (PCR) segment dominates the market and is expected to develop throughout the forecast period. Cost-effectiveness, high sensitivity, and specificity are key factors driving market growth, and they may be used to basic automated systems. Additionally, PCR, another important driver of this section, can determine the sequencing of many diseases' unknown etiology. Furthermore, the next-generation sequencing segment is expected to grow rapidly during the forecast period owing to higher sensitivity to identify low-frequency variants, quicker turnaround duration for large sample volumes, the ability to sequence hundreds to thousands of genes or gene regions concurrently.

Global Companion Diagnostics Market – By Indication

Based on indication, global companion diagnostics market is divided into Cancer, Neurological Disorders, Cardiovascular Diseases, and Infectious Diseases. In 2022, the cancer segment held the highest market share. Increased cancer prevalence, an increase in the number of cancer R&D activities, an increase in the number of unmet needs for cancer treatment, an increase in the number of FDA-approved companion diagnostics, and increased patient awareness about personalized medicine are some of the key factors driving the growth of the oncology segment. The cancer segment includes lung cancer, breast cancer, blood cancer, and colorectal cancer. Amongst them, lung cancer holds the highest market share. Companion diagnostic tests (CDXs) are regarded mandatory in the decision-making process for lung cancer treatment with targeted treatments. Individuals with lung cancer who undergo companion diagnostics as part of their initial treatment have a higher chance of surviving than those who do not. Globally, the increasing incidence rate of non-small cell lung cancer (NSCLC), combined with an increase in the development of oncology companion diagnostic tests for the disease, is likely to drive sector growth.

Global Companion Diagnostics Market – By End User

Based on end user, global companion diagnostics market is segmented into Pharmaceutical & Biopharmaceutical, Reference Laboratories, and Contract Research Organizations. In 2022, the pharmaceutical and biopharmaceutical industry held a majority share in the market. The increasing importance of companion diagnostic biomarkers, as well as the growing usage of companion diagnostics in drug development.

Global Companion Diagnostics Market – By Region

Regionally, global companion diagnostics market is segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America had a sizable market share in 2022 and is expected to expand throughout the forecast period. The high prevalence of various forms of malignancies among the American population drives the North American market. In Canada, the number of cancer patients is increasing over time. As stated by the Canadian Cancer Society, cancer accounts for around 28.2% of all fatalities in Canada. Also, the number of patients with cancer in Mexico is increasing, resulting in increased costs to the country per capita each year. According to the Pan American Health Organization, Mexico had 190,667 cancer cases, with 83,476 cancer patients dying. According to the American Society of Clinical Oncology, the number of cancer cases in Mexico will climb to 1,262,861 over the next decade. Asia Pacific offers significant opportunities for key participants in the companion diagnostics market due to its huge population base, rising awareness of companion diagnostics, development of healthcare infrastructure, and growing demand for advanced treatments.

Competitive Landscape

Major players operating in global companion diagnostics market include Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, and Guardant Health Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In May 2021 - Amgen Inc., QIAGEN N.V. officially confirmed the expansion of companion diagnostic (CDx) claims for the therascreen KRAS RGQ PCR Kit (therascreen KRAS Kit) (AMGN) following regulatory approval in the United States as a companion diagnostic to assist in the detection of non-small cell lung cancer (NSCLC) patients who may be qualified for treatment with LUMAKRASTM (sotorasib).

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period – 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Product/ Service Segmentation	Product & Service, Technology, Indication, End User, Region
Key Players	Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, Guardant Health Inc.

By Product & Service

Assays, Kits & Reagents
Software & Services

By Technology

Polymerase Chain Reaction
Next-generation Sequencing
In Situ Hybridization
Immunohistochemistry

By Indication

Cancer
Neurological Disorders
Cardiovascular Diseases
Infectious Diseases

By End User

Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
Contract Research Organizations

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Companion Diagnostics Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing Cases of Adverse Drug Reactions
    2. Co-development of Drug and Diagnostic Technology
  2. Restraints
    1. High Cost of Drug Development and Associated Clinical Trials
  3. Opportunities
    1. Rising Demand for Next Generation Sequencing
  4. Challenges
    1. Reimbursement Issues Among Many Countries
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Companion Diagnostics Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
    1. Assays, Kits & Reagents
    2. Software & Services
  2. By Technology
    1. Polymerase Chain Reaction
    2. Next-generation Sequencing
    3. In Situ Hybridization
    4. Immunohistochemistry
    5. Others
  3. By Indication
    1. Cancer
      1. Lung Cancer
      2. Breast Cancer
      3. Blood Cancer
      4. Colorectal Cancer
      5. Others
    2. Neurological Disorders
    3. Cardiovascular Diseases
    4. Infectious Diseases
    5. Others
  4. By End User
    1. Pharmaceutical & Biopharmaceutical
    2. Reference Laboratories
    3. Contract Research Organizations
    4. Others
  5. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Companion Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
  2. By Technology
  3. By Indication
  4. By End User
  5. By Country
    1. US
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    2. Canada
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
Europe Companion Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
  2. By Technology
  3. By Indication
  4. By End User
  5. By Country
    1. Germany
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    2. UK
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    3. Italy
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    4. France
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    5. Spain
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    6. The Netherlands
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    7. Rest of Europe
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
Asia-Pacific Companion Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
  2. By Technology
  3. By Indication
  4. By End User
  5. By Country
    1. China
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    2. India
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    3. Japan
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    4. South Korea
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    5. Australia & New Zealand
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    6. Indonesia
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    7. Malaysia
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    8. Singapore
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    9. Philippines
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    10. Vietnam
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    11. Rest of APAC
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
Latin America Companion Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
  2. By Technology
  3. By Indication
  4. By End User
  5. By Country
    1. Brazil
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    2. Mexico
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    3. Argentina
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    4. Peru
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    5. Rest of LATAM
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
Middle East & Africa Companion Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Product & Service
  2. By Technology
  3. By Indication
  4. By End User
  5. By Country
    1. Saudi Arabia
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    2. UAE
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    3. Qatar
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    4. Kuwait
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    5. South Africa
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    6. Nigeria
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    7. Algeria
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
    8. Rest of MEA
      1. By Product & Service
      2. By Technology
      3. By Indication
      4. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Companion Diagnostics Company Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Companion Diagnostics Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Abbott Laboratories Inc.
2. Agilent Technologies Inc.
3. F. Hoffmann-La Roche Ltd
4. Biomerieux SA
5. Qiagen NV
6. Siemens Healthcare
7. Thermo Fisher Scientific Inc.
8. Danaher Corporation (Beckman Coulter Inc.)
9. Almac Group
10. Illumina Inc.
11. Myriad Genetics Inc.
12. Sysmex Corporation
13. Abnova Corporation
14. Guardant Health Inc
15. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Companion Diagnostics Segmentation

Figure 2 Global Companion Diagnostics Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 5 Global Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 6 Global Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 7 Global Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 8 Global Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 9 Global Companion Diagnostics Market Share, By Region, By Value, 2019–2029

Figure 10 North America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 11 North America Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 12 North America Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 13 North America Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 14 North America Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 15 North America Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 16 US Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 17 US Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 18 US Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 19 US Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 20 US Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 21 Canada Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 22 Canada Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 23 Canada Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 24 Canada Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 25 Canada Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 26 Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 27 Europe Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 28 Europe Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 29 Europe Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 30 Europe Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 31 Europe Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 32 Germany Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 33 Germany Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 34 Germany Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 35 Germany Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 36 Germany Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 37 UK Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 38 UK Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 39 UK Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 40 UK Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 41 UK Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 42 Italy Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 43 Italy Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 44 Italy Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45 Italy Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 46 Italy Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 47 France Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 48 France Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 49 France Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 50 France Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 51 France Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 52 Spain Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 53 Spain Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 54 Spain Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 55 Spain Companion Diagnostics Market Share, By Flow Rate, By Value, 2019–2029

Figure 56 Spain Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 57 The Netherlands Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 58 The Netherlands Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 59 The Netherlands Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 60 The Netherlands Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 61 The Netherlands Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 62 Rest of Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 63 Rest of Europe Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 64 Rest of Europe Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 65 Rest of Europe Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 66 Rest of Europe Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 67 Asia-Pacific Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 68 Asia-Pacific Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 69 Asia-Pacific Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 70 Asia-Pacific Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 71 Asia-Pacific Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 72 Asia-Pacific Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 73 China Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 74 China Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 75 China Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 76 China Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 77 China Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 78 India Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 79 India Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 80 India Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 81 India Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 82 India Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 83 Japan Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 84 Japan Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 85 Japan Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 86 Japan Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 87 Japan Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 88 South Korea Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 89 South Korea Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 90 South Korea Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 91 South Korea Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 92 South Korea Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 93 Australia & New Zealand Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 94 Australia & New Zealand Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 95 Australia & New Zealand Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 96 Australia & New Zealand Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 97 Australia & New Zealand Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 98 Indonesia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 99 Indonesia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 100 Indonesia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 101 Indonesia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 102 Indonesia Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 103 Malaysia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 104 Malaysia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 105 Malaysia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 106 Malaysia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 107 Malaysia Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 108 Singapore Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 109 Singapore Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 110 Singapore Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 111 Singapore Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 112 Singapore Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 113 Philippines Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 114 Philippines Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 115 Philippines Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 116 Philippines Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 117 Philippines Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 118 Vietnam Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 119 Vietnam Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 120 Vietnam Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 121 Vietnam Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 122 Vietnam Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 123 Rest of APAC Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 124 Rest of APAC Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 125 Rest of APAC Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 126 Rest of APAC Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 127 Rest of APAC Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 128 Latin America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 129 Latin America Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 130 Latin America Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 131 Latin America Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 132 Latin America Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 133 Latin America Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 134 Brazil Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 135 Brazil Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 136 Brazil Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 137 Brazil Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 138 Brazil Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 139 Mexico Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 140 Mexico Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 141 Mexico Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 142 Mexico Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 143 Mexico Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 144 Argentina Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 145 Argentina Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 146 Argentina Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 147 Argentina Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 148 Argentina Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 149 Peru Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 150 Peru Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 151 Peru Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 152 Peru Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 153 Peru Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 154 Rest of LATAM Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 155 Rest of LATAM Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 156 Rest of LATAM Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 157 Rest of LATAM Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 158 Rest of LATAM Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 159 Middle East & Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 160 Middle East & Africa Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 161 Middle East & Africa Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 162 Middle East & Africa Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 163 Middle East & Africa Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 164 Middle East & Africa Companion Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 165 Saudi Arabia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 166 Saudi Arabia Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 167 Saudi Arabia Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 168 Saudi Arabia Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 169 Saudi Arabia Companion Diagnostics Market Share, By Distribution Indication, By Value, 2019–2029

Figure 170 UAE Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 171 UAE Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 172 UAE Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 173 UAE Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 174 UAE Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 175 Qatar Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 176 Qatar Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 177 Qatar Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 178 Qatar Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 179 Qatar Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 180 Kuwait Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 181 Kuwait Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 182 Kuwait Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 183 Kuwait Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 184 Kuwait Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 185 South Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 186 South Africa Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 187 South Africa Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 188 South Africa Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 189 South Africa Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 190 Nigeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 191 Nigeria Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 192 Nigeria Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 193 Nigeria Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 194 Nigeria Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 195 Algeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 196 Algeria Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 197 Algeria Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 198 Algeria Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 199 Algeria Companion Diagnostics Market Share, By End User, By Value, 2019–2029

Figure 200 Rest of MEA Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Figure 201 Rest of MEA Companion Diagnostics Market Share, By Product & Service, By Value, 2019–2029

Figure 202 Rest of MEA Companion Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 203 Rest of MEA Companion Diagnostics Market Share, By Indication, By Value, 2019–2029

Figure 204 Rest of MEA Companion Diagnostics Market Share, By End User, By Value, 2019–2029

List of Tables

Table 1 Global Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 2 Global Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 3 Global Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4 Global Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 5 Global Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 6 Global Companion Diagnostics Market Size, By Region, By Value, 2019–2029

Table 7 North America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 8 North America Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 9 North America Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 10 North America Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 11 North America Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 12 North America Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 13 US Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 14 US Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 15 US Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 16 US Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 17 US Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 18 Canada Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 19 Canada Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 20 Canada Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 21 Canada Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 22 Canada Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 23 Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 24 Europe Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 25 Europe Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 26 Europe Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 27 Europe Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 28 Europe Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 29 Germany Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 30 Germany Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 31 Germany Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 32 Germany Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 33 Germany Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 34 UK Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 35 UK Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 36 UK Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 37 UK Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 38 UK Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 39 Italy Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 40 Italy Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 41 Italy Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 42 Italy Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 43 Italy Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 44 France Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 45 France Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 46 France Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 47 France Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 48 France Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 49 Spain Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 50 Spain Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 51 Spain Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 52 Spain Companion Diagnostics Market Size, By Flow Rate, By Value, 2019–2029

Table 53 Spain Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 54 The Netherlands Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 55 The Netherlands Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 56 The Netherlands Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 57 The Netherlands Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 58 The Netherlands Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 59 Rest of Europe Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 60 Rest of Europe Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 61 Rest of Europe Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 62 Rest of Europe Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 63 Rest of Europe Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 64 Asia-Pacific Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 65 Asia-Pacific Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 66 Asia-Pacific Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 67 Asia-Pacific Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 68 Asia-Pacific Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 69 Asia-Pacific Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 70 China Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 71 China Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 72 China Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 73 China Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 74 China Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 75 India Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 76 India Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 77 India Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 78 India Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 79 India Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 80 Japan Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 81 Japan Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 82 Japan Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 83 Japan Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 84 Japan Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 85 South Korea Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 86 South Korea Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 87 South Korea Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 88 South Korea Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 89 South Korea Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 90 Australia & New Zealand Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 91 Australia & New Zealand Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 92 Australia & New Zealand Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 93 Australia & New Zealand Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 94 Australia & New Zealand Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 95 Indonesia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 96 Indonesia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 97 Indonesia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 98 Indonesia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 99 Indonesia Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 100 Malaysia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 101 Malaysia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 102 Malaysia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 103 Malaysia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 104 Malaysia Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 105 Singapore Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 106 Singapore Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 107 Singapore Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 108 Singapore Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 109 Singapore Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 110 Philippines Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 111 Philippines Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 112 Philippines Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 113 Philippines Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 114 Philippines Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 115 Vietnam Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 116 Vietnam Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 117 Vietnam Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 118 Vietnam Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 119 Vietnam Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 120 Rest of APAC Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 121 Rest of APAC Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 122 Rest of APAC Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 123 Rest of APAC Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 124 Rest of APAC Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 125 Latin America Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 126 Latin America Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 127 Latin America Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 128 Latin America Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 129 Latin America Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 130 Latin America Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 131 Brazil Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 132 Brazil Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 133 Brazil Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 134 Brazil Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 135 Brazil Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 136 Mexico Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 137 Mexico Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 138 Mexico Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 139 Mexico Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 140 Mexico Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 141 Argentina Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 142 Argentina Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 143 Argentina Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 144 Argentina Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 145 Argentina Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 146 Peru Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 147 Peru Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 148 Peru Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 149 Peru Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 150 Peru Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 151 Rest of LATAM Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 152 Rest of LATAM Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 153 Rest of LATAM Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 154 Rest of LATAM Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 155 Rest of LATAM Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 156 Middle East & Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 157 Middle East & Africa Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 158 Middle East & Africa Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 159 Middle East & Africa Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 160 Middle East & Africa Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 161 Middle East & Africa Companion Diagnostics Market Size, By Country, By Value, 2019–2029

Table 162 Saudi Arabia Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 163 Saudi Arabia Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 164 Saudi Arabia Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 165 Saudi Arabia Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 166 Saudi Arabia Companion Diagnostics Market Size, By Distribution Indication, By Value, 2019–2029

Table 167 UAE Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 168 UAE Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 169 UAE Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 170 UAE Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 171 UAE Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 172 Qatar Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 173 Qatar Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 174 Qatar Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 175 Qatar Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 176 Qatar Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 177 Kuwait Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 178 Kuwait Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 179 Kuwait Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 180 Kuwait Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 181 Kuwait Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 182 South Africa Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 183 South Africa Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 184 South Africa Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 185 South Africa Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 186 South Africa Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 187 Nigeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 188 Nigeria Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 189 Nigeria Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 190 Nigeria Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 191 Nigeria Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 192 Algeria Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 193 Algeria Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 194 Algeria Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 195 Algeria Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 196 Algeria Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 197 Rest of MEA Companion Diagnostics Market Size, By Value (USD Billion), 2019–2029

Table 198 Rest of MEA Companion Diagnostics Market Size, By Product & Service, By Value, 2019–2029

Table 199 Rest of MEA Companion Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 200 Rest of MEA Companion Diagnostics Market Size, By Indication, By Value, 2019–2029

Table 201 Rest of MEA Companion Diagnostics Market Size, By End User, By Value, 2019–2029

Table 202 Abbott Laboratories Inc. Company Overview

Table 203 Abbott Laboratories Inc. Financial Overview

Table 204 Agilent Technologies Inc. Company Overview

Table 205 Agilent Technologies Inc. Financial Overview

Table 206 F.Hoffmann-La Roche Ltd Company Overview

Table 207 F.Hoffmann-La Roche Ltd Financial Overview

Table 208 Biomerieux SA Company Overview

Table 209 Biomerieux SA Financial Overview

Table 210 Qiagen NV Company Overview

Table 211 Qiagen NV Financial Overview

Table 212 Siemens Healthcare Company Overview

Table 213 Siemens Healthcare Financial Overview

Table 214 Thermo Fisher Scientific Inc. Company Overview

Table 215 Thermo Fisher Scientific Inc. Financial Overview

Table 216 Danaher Corporation (Beckman Coulter Inc.) Company Overview

Table 217 Danaher Corporation (Beckman Coulter Inc.) Financial Overview

Table 218 Almac Group Company Overview

Table 219 Almac Group Financial Overview

Table 220 Illumina Inc. Company Overview

Table 221 Illumina Inc. Financial Overview

Table 222 Myriad Genetics Inc. Company Overview

Table 223 Myriad Genetics Inc. Financial Overview

Table 224 Sysmex Corporation Company Overview

Table 225 Sysmex Corporation Financial Overview

Table 226 Abnova Corporation Company Overview

Table 227 Abnova Corporation Financial Overview

Table 228 Guardant Health Inc Company Overview

Table 229 Guardant Health Inc Financial Overview

Market Segmentation

By Product & Service

Assays, Kits & Reagents
Software & Services

By Technology

Polymerase Chain Reaction
Next-generation Sequencing
In Situ Hybridization
Immunohistochemistry

By Indication

Cancer
Neurological Disorders
Cardiovascular Diseases
Infectious Diseases

By End User

Pharmaceutical & Biopharmaceutical Companies
Reference Laboratories
Contract Research Organizations

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current market size of Global Companion Diagnostics Market?

Ans: Global Companion Diagnostics Market size was estimated at USD 6.12 billion in 2022.

2. What are the major factors driving the growth of Global Companion Diagnostics Market?

Ans: Major factors driving the growth of Global Companion Diagnostics Market include increasing cases of adverse drug reactions and co-development of drug and diagnostic technology.

3. Which segment accounts for the highest market share in the Global Companion Diagnostics Market by product & service?

Ans: The assays, kits & reagents segment is expected to hold the highest market share in the Global Companion Diagnostics Market by product and service.

4. Which segment accounts for highest market share in the Global Companion Diagnostics Market by technology?

Ans: The polymerase chain reaction segment is expected to hold the highest market share in Global Companion Diagnostics Market by technology.

5. Name the key players in Global Companion Diagnostics Market.

Ans: Key players in Global Companion Diagnostics Market include Abbott Laboratories Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, Biomerieux SA, Qiagen NV, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Almac Group, Illumina Inc., Myriad Genetics Inc., Sysmex Corporation, Abnova Corporation, and Guardant Health Inc.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4250
GROUP LICENSE
$ 5250
ENTERPRISE LICENSE
$ 6000

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.